HOME >> MEDICINE >> NEWS
Amid food safety concerns, K-State professor believes consumers ready for irradiated meat products

proved for irradiating meat. One involves exposing the product to a beam of electrons that destroy the bacteria, while the second involves exposing the product to radioactive cobalt, which emits gamma rays that penetrate the product in the same manner an X-ray would, to kill pathogens.

While stores are currently offering consumers a choice between ground beef processed by the traditional method or irradiated ground beef, Fox envisions a point where just irradiated meats are the norm rather than the exception.

"It think we will get to the point where it's essentially all irradiated products," Fox said. "If you look at milk, it's very difficult to find unpasteurized milk in the store. I think certainly 20 years from now we will look back at the fact that we were consuming non-irradiated ground beef and being somewhat amazed that we were doing that."

Unfortunately, Fox said, the process is not free and adds approximately 6 to 10 cents per pound to the processing cost. That additional cost will ultimately be passed on to consumers. But he believes consumers will be willing to pay extra for a safer product. Ultimately, Fox said the pace at which we see the share of irradiated beef growing in the market will depend on consumer demand.

Although irradiation adds an extra layer of defense against foodborne pathogens, Fox cautions that appropriate food handling techniques should still be followed.

"It's important to realize that the product will spoil," Fox said. "It is not sterile and should be handled in exactly the same way you would a regular product."


'"/>

Contact: John A. (Sean) Fox
jafox@k-state.edu
785-532-4446
Kansas State University
31-Oct-2002


Page: 1 2

Related medicine news :

1. Major review of subway systems suggests potential for significant health and safety hazards
2. Hormone therapy controversy raises drug safety issues
3. Article highlights confusion about Homeland Security safety symbols
4. New findings on patient safety at childrens hospitals
5. Data protection rules may risk patient safety on wards
6. First-ever safety study of medical cannabis use in Canada launched
7. FDA tried to discredit whistleblower over drug safety claims
8. Study clarifies impact of age on safety of warfarin treatment for atrial fibrillation
9. Study of cancer trials finds significant safety improvement
10. Screening for virus RNA could increase safety of organ & tissue transplantation
11. Study questions safety of heart procedures at hospitals without cardiac surgery programs

Post Your Comments:
(Date:8/20/2014)... 20, 2014 Hope For The Warriors® ... Celebration to be hosted in Washington, DC on Thursday, ... This signature event honors the courage of our wounded ... fallen. Proceeds from the Got Heart, Give Hope® Celebration ... dedicated to restoring a sense of self, restoring the ...
(Date:8/20/2014)... WA (PRWEB) August 20, 2014 “Have you ... an auto accident and personal injury lawyer serving the greater ... that incident? If so, then keep reading . , ... that individuals injured in an auto accident can use to ... Jones explains that a personal injury insurance claim will allow ...
(Date:8/20/2014)... The “Human Insulin Market by ... Premixed), Modern Human Insulin (Rapid Acting, Long Acting, ... Tresiba, Others) - Forecast to 2019” provides a ... current market trends,and strategies impacting the global human ... of the revenue and share analysis. , Browse ...
(Date:8/20/2014)... Burlingame, CA (PRWEB) August 20, 2014 ... publishers to speech-enable their websites and create a new ... users to consume content by listening to a narration ... in multiple reader genders and languages. Users can ... work, check social networks, while consuming content. ...
(Date:8/20/2014)... New York (PRWEB) August 20, 2014 Over ... the Global Bureau of Disease, low back pain is the ... the most common reasons for missed work. Americans spend at ... this pain. , Most cases of back pain are not ... mechanical (non-organic) origin. , For example, Pete, a busy accountant, ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors Announces Got Heart, Give Hope Celebration in Washington, DC 2Health News:Five Questions to Determine Who Qualifies for a Personal Injury Claim Recently Released by The Jones Firm in Recent Article 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Mixberry Media, First To Offer Article Voice Narration with Integrated Audio Advertising 2Health News:Physical Therapists Learn to Relieve Low Back Pain 2
(Date:8/19/2014)... British Columbia and MENLO PARK, Calif. ... (OTCQB: DMPI) ("DelMar" "the company") announced today a protocol ... trial had been filed with the U.S. Food and Drug ... 50mg/m 2 has been opened at three clinical trial ... company also confirmed that gross proceeds of US$2.9 million have ...
(Date:8/19/2014)... 2014 ,Weight Loss- Market Analysis, ... report provides comprehensive insights about phase III pipeline drugs ... of the report is to establish the understanding for ... across the different countries and regions. While the leading ... also provides details on the drug master filings across ...
(Date:8/18/2014)... Israel , Aug. 19, 2014 Immune ... Stockholm : "IMNP"), a biotechnology company, today announced ... its common stock on the NASDAQ Capital Market has been ... NASDAQ OMX Group. IMMUNE,s common stock is expected to begin ... trading on August 21, 2014 under the symbol IMNP. ...
Breaking Medicine Technology:DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 2DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 3DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 4DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 5DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 6DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 7Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 2Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 3Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 4Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 2Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 3Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 4
Cached News: